Ovarian cancer and non-small-cell lung cancer (NSCLC) cells were made more susceptible to DDP when supplemented with EGCG by increasing ROS generation and CTR1 expression through activating the ERK1/2/NEAT1 pathway (Chen A. et al., 2020). Here, MAPK3 is linked to non-small cell lung carcinoma.